Open Access

TIPE1 impairs ovarian tumor growth by promoting caspase-dependent apoptosis

  • Authors:
    • Tingting Li
    • Lei Jia
    • Yu Deng
    • Song Quan
    • Bo Wang
  • View Affiliations

  • Published online on: October 15, 2020     https://doi.org/10.3892/ol.2020.12227
  • Article Number: 365
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Tumor necrosis factor‑α‑induced protein 8‑like 1 (TIPE1) functions as a tumor suppressor in several types of cancer, including lung and breast cancer. The present study aimed to determine the level of expression and the function of TIPE1 in ovarian cancer. TIPE1 expression was determined in tissue microarrays and ovarian cancer cells, and these data were analyzed to assess the association between TIPE1 expression and prognosis in patients with ovarian cancer. The potential antitumor effects of TIPE1 were investigated in vitro and in a xenograft mouse model. Furthermore, the underlying molecular mechanism by which TIPE1 regulates ovarian cancer growth was determined via flow cytometric analysis, western blotting and rescue experiments. The results of the present study indicated that TIPE1 levels were markedly decreased in ovarian cancer tissues, and its level of expression was associated with a favorable prognosis of patients with ovarian cancer. In addition, ectopic TIPE1 expression significantly impaired A2780 and SKOV3 cell proliferation and colony formation in vitro, which was accompanied by efficient inhibition of xenograft tumor growth in mice. Investigations into the underlying molecular mechanism demonstrated that TIPE1 induced ovarian cancer cell apoptosis by promoting caspase protein expression. Inhibition of caspase‑dependent apoptosis by z‑VAD blocked TIPE1‑mediated inhibition of the proliferation and induction of apoptosis in ovarian cancer cells. Collectively, the results of the present study suggest that TIPE1 may be a potential prognostic predictor and therapeutic target for patients with ovarian cancer.
View Figures
View References

Related Articles

Journal Cover

December-2020
Volume 20 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li T, Jia L, Deng Y, Quan S and Wang B: TIPE1 impairs ovarian tumor growth by promoting caspase-dependent apoptosis. Oncol Lett 20: 365, 2020
APA
Li, T., Jia, L., Deng, Y., Quan, S., & Wang, B. (2020). TIPE1 impairs ovarian tumor growth by promoting caspase-dependent apoptosis. Oncology Letters, 20, 365. https://doi.org/10.3892/ol.2020.12227
MLA
Li, T., Jia, L., Deng, Y., Quan, S., Wang, B."TIPE1 impairs ovarian tumor growth by promoting caspase-dependent apoptosis". Oncology Letters 20.6 (2020): 365.
Chicago
Li, T., Jia, L., Deng, Y., Quan, S., Wang, B."TIPE1 impairs ovarian tumor growth by promoting caspase-dependent apoptosis". Oncology Letters 20, no. 6 (2020): 365. https://doi.org/10.3892/ol.2020.12227